Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Cosmetic Surgery

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1325203

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1325203

Botulinum Toxin

PUBLISHED:
PAGES: 353 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Botulinum Toxin Market to Reach $11 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Botulinum Toxin estimated at US$5.6 Billion in the year 2022, is projected to reach a revised size of US$11 Billion by 2030, growing at aCAGR of 8.8% over the period 2022-2030. Type A, one of the segments analyzed in the report, is projected to record 8.8% CAGR and reach US$11 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Type B segment is readjusted to a revised 7.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 16% CAGR

The Botulinum Toxin market in the U.S. is estimated at US$3.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 16% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.6% and 7.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

Select Competitors (Total 28 Featured) -

  • Ipsen Pharma
  • BNC KOREA
  • EuBiologics Co., Ltd.
  • Gentle Slima"¢
  • New Look New Life Surgical Arts, P.L.L.C.
  • Innomed Technologies, Inc.
  • Suresh Gupta MD, Inc.
Show more
Product Code: MCP-1833

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • COVID-19 Disruptions Impact Botulinum Toxin Business
    • Virtual Care to the Fore amid COVID-19
    • Aesthetic Clinics to Follow Infection-Prevention Measures to Mitigate Risk of COVID-19 Infection Transmission
    • % Rise in Migraine Attacks due to COVID-19 Pandemic for March 2020
    • COVID-19 Disruptions Highlight Significance of Botulinum Toxin Therapy for Associated Medical Conditions
    • Researchers Eye on Botulinum Toxin as Potential Therapeutic Option to Alleviate and Manage COVID-19 Infection
    • Botulinum Toxin - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Botulinum Toxin: An Introduction
    • Outlook
    • Therapeutic BTX Applications Lead
    • Cosmetic BTX Gradually Gains Momentum
    • Factors Propelling the Cosmetic BT Market: In a Nut Shell
    • Percent of Plastic Surgeons Performing Botulinum Toxin Surgical Procedures in Select Countries: 2019
    • Developed Regions Dominate Botulinum Toxin Market
    • Developing Markets to Drive Future Growth
    • Competitive Landscape
    • Intense Competition Characterizes Botulinum Toxin Market
    • Market Share of Leading Players in Global Botulinum Toxin Market: 2019
    • Select Approved Botulinum Toxin Products Worldwide
    • Companies Entering the Fray
    • Pharma Companies Eye Lucrative BT Market
    • Biosimilar BTX Variants Challenge Botox's Leadership
    • Lack of Differentiation among Approved BTX Products
    • Comparison of Leading Neurotoxins - Botox, Dysport and Xeomin by Safety and Efficacy
    • Comparison of Botox®, Dysport® and Xeomin® by Indications and Year of Approval
    • BOTOX®
    • Approvals and Indications of Botox in Select Regions
    • Botox Therapeutic Approvals in the US by Indication
    • Ipsen Counts on New Indications for Future Growth of Dysport
    • Xeomin®
    • Merz
    • Other Products
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Non-Invasive Cosmetic Treatments Bodes Well for BTX Market
    • Non-Surgical Cosmetic Procedures Worldwide (2018): Percentage Breakdown of Procedure Volumes
    • Botulinum Toxin: The Preferred Solution in Facial Injectables Market
    • Cosmetic Botulinum Toxin Procedures Performed Worldwide (2019): Percentage Breakdown of Procedure Volume by Gender
    • Millennials: A Popular Demographic for Botulinum Toxin
    • Cosmetic Botulinum Toxin Procedures Performed Worldwide (2019): Percentage Breakdown of Procedure Volume by Age Group Age Group % Share
    • Therapeutic Areas and Opportunities
    • Botox Therapeutic Applications Uses and Indications
    • Global Therapeutic BTX Neurotoxin Market Breakdown by Therapeutic Indication (2019)
    • Botulinum Toxin Remains Gold Standard for Treatment of Focal Spasticity
    • Rise in the Number of Musculoskeletal Indications: Potential for Growth
    • Unmet Medical Needs Encourage Off-Label Use: A Cause for Concern or Jubilation?
    • Combination Therapies: A Double Whammy Success
    • Botulinum Toxin: Potential Applications in Treatment of Dental Diseases
    • Potential Applications in Dentistry
    • Short-lived Aesthetic Effects: A Strong Business Case for Revision Treatments
    • Novel Injection Systems for Highly Precise Dosage of Botulinum Toxin
    • Longer Life Expectancy and Rising Disposable Incomes Propel Sales of Cosmetic BTX
    • Life Expectancy at Birth in Years of People in Select Countries
    • Life Expectancy at Birth (in Years) of Men and Women by Region
    • Increase in Healthcare Spending Stirs Demand for BTX in Therapeutic Applications
    • Current Health Expenditure (CHE) as Percentage Of Gross Domestic Product (GDP) (%): 2017
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Challenges and Issues
    • Undesirable Side Effects: A Challenge to Reckon With
    • Immunogenicity Undermines Patient Compliance
    • Antigenicity: A Problematic Issue in Drug Development
    • Potential Adverse Side Effects: A Major Barrier to Success
    • Stringent Regulations Delay Market Approvals
    • Higher Product Costs to Challenge Market Growth
    • Consumer Skepticism: The Biggest Challenge to Beat
    • Animal Cruelty:A Part & Parcel of Botox Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Botulinum Toxin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Botulinum Toxin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Botulinum Toxin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Type A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Type A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Type A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Type B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Type B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Type B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Aesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Aesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Aesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Specialty & Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Specialty & Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Specialty & Dermatology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Botulinum Toxin Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • Market Overview
    • Opportunities in Store for Cosmetic BTX
    • Age-wise Distribution for Botulinum Toxin Procedures Performed in the US for the Year 2019
    • Gender Distribution for Botulinum Toxin Procedures Performed in the US (2019)
    • Increasing Demand for Cosmetic Treatments Bodes Well for BTX Market
    • Cosmetic Procedures: Facts and Figures
    • Number of Surgical & Non-Surgical Cosmetic Procedures ('000s) in the US for the Years 2000, 2018 & 2019
    • Top 5 Surgical Cosmetic Procedures in the US - Ranked by the Number of Procedures Performed (In '000s) for 2019
    • Top 4 Non-Surgical Cosmetic Procedures in the US - Ranked by the Number of Procedures Performed ('000s) for 2019
    • Number of Botulinum Toxin Procedures* Performed in the US: 2000, 2016 and 2019
    • Aging Baby Boomers Drive Aesthetic Business
    • US Population by Age Group (2017): Percentage Breakdown for 0-14, 15-24, 25-59 and 65+ Age Groups
    • North American Aging Population by Age Group: 1975-2050
    • Expanding Physician Base Extends Impetus to Growth
    • Therapeutic BTX Seeks Growth Opportunities
    • Approved Therapeutic Indications of Botulinum Toxin in the US by Year of Approval
    • Neurogenic OAB: A Lucrative Market Opportunity
    • Competitive Landscape
    • Major BTX Products and Associated Fillers in the Cosmetic Botulinum Toxin Market
    • Market Share of Leading Brands in the US Boulinum Toxin Market: 2019
    • Dysport Poses Strong Competition to Botox in the Therapeutic Space
    • TABLE 26: USA Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
    • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • Market Overview
    • Non-Surgical Aesthetic Procedures in Japan (2019): Percentage Breakdown of Number of Procedures by Procedure Type Procedure % Share
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
    • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • Market Overview
    • Uptrend in Facial Injectables Market Favors Market Expansion
    • Regulatory Scenario
    • Approved Botulinum Toxin Injections in China
    • Competition
    • Market Share of Leading Players in Chinese Botulinum Toxin Market: 2019
    • TABLE 53: China Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: China 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: China 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: China 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
    • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • Market Overview
    • Botox Approvals and Indications in Select European Countries
    • Non-Surgical Aesthetic Procedures in Select European Countries (2019): Percentage Breakdown of Number of Procedures by Procedure Type
    • Regulations for Botulinum Toxin Usage in the EU
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Botulinum Toxin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Botulinum Toxin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • FRANCE
    • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: France 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: France 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: France 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
    • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Italy 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • Market Overview
    • Snapshots
    • TABLE 101: UK Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: UK 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: Spain 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • RUSSIA
    • Market Overview
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: Russia 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Botulinum Toxin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Botulinum Toxin by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • Market Overview
    • Non-Surgical Aesthetic Procedures in Australia (2019): Percentage Breakdown of Number of Procedures by Procedure Type
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 151: Australia 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • INDIA
    • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • Market Overview
    • Non-Surgical Aesthetic Procedures in India (2019): Percentage Breakdown of Number of Procedures by Procedure Type
    • TABLE 158: India Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 160: India 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 163: India 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 166: India 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • Market Overview
    • Strong Demand for Cosmetic Procedures - Potential for BTX Market
    • Working Women as % of Total Female Population for 2005, 2010, 2015 & 2018
    • Foreign Patients Visiting Korea for Plastic Surgery & Dermatology Procedures as a % of Total Visits of Foreign Patients
    • Competition
    • Market Share of Leading Players in Botulinum Toxin Market In South Korea
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 169: South Korea 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 187: Latin America 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 194: Rest of World Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Rest of World Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 196: Rest of World 16-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2014, 2023 & 2030
    • TABLE 197: Rest of World Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Rest of World Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 199: Rest of World 16-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2014, 2023 & 2030
    • TABLE 200: Rest of World Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Rest of World Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 202: Rest of World 16-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2014, 2023 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!